地舒单抗治疗骨转移疗效怎样?
How effective is the treatment of bone metastases?
The therapeutic effect of denosumab in the treatment of bone metastases:
FREEDOM, a 3-year randomized, double-blind, placebo-controlled phase III clinical trial, evaluated the efficacy and safety of denosumab in the treatment of osteoporosis in postmenopausal women.
Patients were randomized to treatment (desosomeumab 60 mg subcutaneously every 6 months, n = 3902) or placebo (n = 3906). The primary outcome measure was the incidence of new vertebral fractures over the 3-year period, and secondary outcomes included the incidence of hip and nonvertebral fractures and the time to first fracture during the observation period.
The subjects were aged between 60 and 90 years old, with an average age of 72.3 years. The basic spine or total hip T-score value was between -4.0 and -2.5 (the average was -2.8). About 23% of the subjects had a history of at least one fracture before entering this trial. All patients also received daily supplements of 1000 mg of vegetarian calcium and 400 to 800 IU of vitamin D.
The results showed that compared with the placebo group, the incidence of new vertebral fractures in the treatment group was reduced by 68% (2.3% in the treatment group and 7.2% in the placebo group, P < 0.000 1), and the incidence of hip fractures was reduced by 40% (0.7% in the treatment group and 1.2% in the placebo group, P = 0.036), the incidence of non-vertebral fractures was relatively reduced by 20% (6.5% in the treatment group and 8.0% in the placebo group, P =0.011).
In addition, a phase I clinical study conducted in healthy postmenopausal women showed that a dose-dependent decrease in morning urine NTX levels could be observed 2 days after administration, and this decrease could last for 6 months, with the maximum decrease reaching 84% compared with baseline. This effect is reversible. When serum levels disappear, NTX levels can be seen to rise again, which reflects the reversibility of its effect on bone reconstruction. As treatment continues, these effects will persist for a new cycle.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)